Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy
Saccone, Valentina,Consalvi, Silvia,Puri, Pier Lorenzo,Mascagni, Paolo
申请号：
AU2012368818
公开号：
AU2012368818B2
申请日:
2012.02.03
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to a method for treating muscular dystrophy which comprises administering diethyl- [ 6- ( 4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl ) - naphthalen-2-yl-methyl ] -ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof to a patient in need of such a treatment. The invention further relates to a method for treating muscular dystrophy which comprises administering diethyl- [ 6- ( 4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl ) - naphthalen-2-yl-methyl ] -ammonium chloride or other pharmaceutically acceptable' salts and/or solvates thereof in combination, with one or more additional anti-inflammatory active agents to a patient in need of such a treatment.
